Diab N, Brister D, Kum E, Wahab M, et al. Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial. Eur Respir J 2026;67:2501573.
PMID: 41198391